Fuji Photo Film Co. Ltd. has invested
$8.3 million in Perseus Proteomics Inc. Together, the Tokyo-based companies will
focus on developing a medical material by combining Fuji’s proprietary materials
with an imaging technique that enables visualization of biomolecules. They plan
to develop a diagnostic system using disease-related biomarkers and to discover
drug candidate compounds. Fuji believes that the investment will facilitate its
full entry into the antibody therapeutics market.
MORE FROM PHOTONICS MEDIA